Navigation Links
New Herbal-Based Sexual Supplement Hits Market Today
Date:2/8/2016

NEW YORK, Feb. 8, 2016 /PRNewswire/ -- Labvantage Lx, a newcomer to the dietary supplement market, today announces its first male sexual enhancement product, EnduramenT. Setting a new standard in herbal-based enhancement, EnduramenT combines proven ethnobotanicals with a patented biomedical breakthrough molecule that promotes the controlled release of nitric oxide, the chemical compound responsible for many biological functions including erectile function.

Forgoing the use of prescription medications, scientists working on EnduramenT discovered the synergy of the nitric oxide and blood flow stimulating effects of old world ethnobotanicals with the nitric oxide releasing power of the patented molecule VEEN. The EnduramenT formula combines these proven ethnobotanicals with VEEN, which has been shown in clinical studies to improve nitric oxide levels in a controlled manner in response to various stimuli, among them increased blood pressure, thus restoring youthful vigor and function in the body.

EnduramenT
EnduramenT

An independent survey of men ages 30-60 showed that the patent pending EnduramenT formula addresses the problems of male desire and performance by combining two major botanicals, Muira puama extract with Pueraria lobata extract. This fast acting formulation increases libido while enhancing erection quality - providing a firmer, longer-lasting erection and overall improved sexual experience for both partners. In this recent consumer study conducted on behalf of Labvantage Lx, 89% of users reported their sexual partners as also having a marked improvement in satisfaction with the addition of EnduramenT.

EnduramenT is an herbal-based scientifically formulated product using cutting edge desiccated liposomal delivery technology to deliver effective amounts of the active ingredients quickly into the blood stream through the highly vascularized oral mucosa. The formula is designed to be taken only minutes prior to sexual activity and its onset can be felt within minutes of its absorption under the tongue. Upon taking this supplement as directed, 89% of healthy men ages 30-60 experienced a harder, firmer and longer lasting erection.

Labvantage Lx is committed to removing the guesswork from the herbal supplement market by offering only herbal-based products that have yielded positive results according to detailed testimonials. EnduramenT is available to purchase online at http://www.labvlx.com/.

About Labvantage Lx:
Labvantage Lx Corporation is committed to developing, manufacturing and marketing effective herbal-based supplements that are proven to deliver results based on our clinically tested testosterone-enhancing formula. With the intent to redefine anti-aging, male enhancement, women's sexual health and fitness, Labvantage Lx applies real science to create safe, superior alternatives to prescription drugs and unproven over-the-counter supplements that address these concerns. For more information about our products, please visit http://www.labvlx.com/.

Press Contact: The Narrative Group
Anna MacLellan / (646) 435-9810
Email 

 

Photo - http://photos.prnewswire.com/prnh/20160208/330743 
Logo - http://photos.prnewswire.com/prnh/20160208/330744LOGO 


'/>"/>
SOURCE Labvantage Lx
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Palatin Technologies Strengthens Intellectual Property Surrounding Use of Bremelanotide for Female Sexual Dysfunction
2. Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026
3. Need to Prevent Sexually Transmitted Diseases (STIs) for Public Health Drives Global Contraceptives Market: Transparency Market Research
4. U.S. Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2016 - Supplier Shares and Country Forecasts
5. United States Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2016: Emerging Opportunities and Growth Strategies for Suppliers
6. S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
7. S1 Biopharma Supports FDA Advisory Committees Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
8. Palatin Supports FDA Advisory Committees Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
9. Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health
10. Elsevier Announces Publishing Agreement with the International Society for Sexual Medicine
11. Spinal surgery diminishes low back pain, improves sexual function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers ... an innovative way to use nonlinear optical imaging to ... new drugs. ... will show how researchers from BioPharmX and the Wellman ... used a suite of imaging techniques in what is ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") ... Surgical facility in Las Piedras, Puerto Rico ... and blades. ... the facility sustained minor structural damage, temporary loss of ... Repairs have been completed, manufacturing operations have resumed, and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):